marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
Catalyst Biosciences Balance Sheet 2011-2024 | CBIO
Annual Balance Sheet Catalyst Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-33.1 M | -24.6 M | -42 M | -24.3 M | -13.6 M | -31.2 M | -9.39 M | 9.14 M | 4.65 M | -56.4 M | -53.3 M | -80.3 M | -104 M |
Long Term Debt |
199 K | 121 K | 408 K | 981 K | - | - | - | - | - | - | 283 K | 1.14 M | 1.99 M |
Long Term Debt Current |
210 K | 492 K | 1.98 M | 663 K | 483 K | - | - | - | - | - | 853 K | 851 K | 1.24 M |
Total Non Current Liabilities |
- | - | - | 981 K | 1.32 M | 174 K | - | 54 K | 340 K | - | 283 K | 2.32 M | 5.23 M |
Total Current Liabilities |
20 M | 12.2 M | 14.2 M | 17.8 M | 28.9 M | 4.8 M | 8.74 M | 22 M | 37.8 M | 2.34 M | 11 M | 11.3 M | 78.6 M |
Total Liabilities |
38.1 M | 12.5 M | 14.6 M | 18.8 M | 30.2 M | 4.98 M | 8.74 M | 22 M | 38.1 M | 2.91 M | 11.3 M | 13.7 M | 83.8 M |
Deferred Revenue |
39 K | 145 K | 230 K | 1.98 M | 15 M | - | 212 K | 283 K | 438 K | - | - | 2.36 M | 57.7 M |
Retained Earnings |
-85.5 M | 7.4 M | -403 M | -315 M | -259 M | -203 M | -173 M | -148 M | -131 M | -313 M | -281 M | -234 M | -227 M |
Total Assets |
117 M | 84.8 M | 55.7 M | 94.8 M | 98.6 M | 125 M | 39.5 M | 38.1 M | 69.5 M | 112 M | 146 M | 190 M | 258 M |
Cash and Cash Equivalents |
33.5 M | 25.2 M | 44.3 M | 30.4 M | 15.4 M | 31.2 M | 14.5 M | 10.3 M | 29.1 M | 1.54 M | 2.83 M | 3.4 M | 107 M |
Book Value |
78.5 M | 72.2 M | 41.1 M | 76.1 M | 68.3 M | 120 M | 30.8 M | 16.1 M | 31.4 M | 109 M | 135 M | 176 M | 174 M |
Total Shareholders Equity |
-15.8 M | 42.5 M | 41.1 M | 76.1 M | 68.3 M | 120 M | 30.8 M | 16.1 M | 31.4 M | -109 M | -103 M | -93.3 M | 174 M |
All numbers in USD currency
Quarterly Balance Sheet Catalyst Biosciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
1.1 M | 1.3 M | 175 K | 199 K | - | - | - | - | - | - | - | 408 K | 550 K | 1.05 M | 806 K | 981 K | 981 K | 981 K | 981 K | 1.32 M | 1.32 M | 1.32 M | 1.32 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 142 K | 283 K | 283 K | 283 K | 283 K | 1.14 M | 1.14 M | 1.14 M | 1.14 M | 1.99 M | 1.99 M | 1.99 M | 1.99 M |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.12 M | - | - | - | 1.63 M | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
26.8 M | 27.6 M | 33.2 M | 38.1 M | 6.45 M | 7.4 M | 11.4 M | 16.8 M | 1.64 M | 4.31 M | 13.2 M | 14.6 M | 17.8 M | 16.6 M | 15 M | 18.8 M | 18.8 M | 18.8 M | 18.8 M | 30.2 M | 30.2 M | 30.2 M | 30.2 M | 4.98 M | 4.98 M | 4.98 M | 4.98 M | 8.74 M | 8.74 M | 8.74 M | 8.74 M | 22 M | 22 M | 22 M | 22 M | 38.1 M | 38.1 M | 38.1 M | 38.1 M | 3.46 M | 3.46 M | 2.91 M | 2.91 M | 3.64 M | 11.3 M | 11.3 M | 11.3 M | 13.7 M | 13.7 M | 13.7 M | 13.7 M | 83.8 M | 83.8 M | 83.8 M | 83.8 M |
Deferred Revenue |
36 K | 57 K | 35 K | 39 K | - | - | - | - | - | - | - | 230 K | 853 K | 2.04 M | 1.33 M | 1.98 M | 1.98 M | 1.98 M | 1.98 M | 15 M | 15 M | 15 M | 15 M | - | - | - | - | 212 K | 530 K | 848 K | 259 K | 283 K | 283 K | 283 K | 283 K | 438 K | 438 K | 438 K | 438 K | 1.75 M | 1.75 M | 25 K | 61 K | 1.19 M | - | - | - | 2.36 M | 2.36 M | 2.36 M | 2.36 M | 57.7 M | 57.7 M | 57.7 M | 57.7 M |
Retained Earnings |
-73.4 M | -74.5 M | -78 M | -85.5 M | -415 M | -413 M | -411 M | -411 M | -370 M | -366 M | -417 M | -403 M | -382 M | -357 M | -337 M | -315 M | -315 M | -315 M | -315 M | -259 M | -259 M | -259 M | -259 M | -203 M | -203 M | -203 M | -203 M | -173 M | -173 M | -173 M | -173 M | -148 M | -148 M | -148 M | -148 M | -131 M | -131 M | -131 M | -131 M | -116 M | -116 M | -313 M | -313 M | -110 M | -281 M | -281 M | -281 M | -234 M | -234 M | -234 M | -234 M | -227 M | -227 M | -227 M | -227 M |
Total Assets |
125 M | 121 M | 122 M | 117 M | 9.96 M | 12.4 M | 18.8 M | 28.4 M | 31 M | 83.4 M | 40.3 M | 55.7 M | 78.5 M | 102 M | 119 M | 94.8 M | 94.8 M | 94.8 M | 94.8 M | 98.6 M | 98.6 M | 98.6 M | 98.6 M | 125 M | 125 M | 125 M | 125 M | 39.5 M | 39.5 M | 39.5 M | 39.5 M | 38.1 M | 38.1 M | 38.1 M | 38.1 M | 69.5 M | 69.5 M | 69.5 M | 69.5 M | 2.98 M | 2.98 M | 112 M | 112 M | 5.27 M | 146 M | 146 M | 146 M | 190 M | 190 M | 190 M | 190 M | 258 M | 258 M | 258 M | 258 M |
Cash and Cash Equivalents |
15.9 M | 16.1 M | 29.8 M | 33.5 M | 2.23 M | 6.92 M | 8.1 M | 21.7 M | 23.1 M | 75.4 M | 34.8 M | 44.3 M | 59.2 M | 73.6 M | 83 M | 30.4 M | 30.4 M | 30.4 M | 30.4 M | 15.4 M | 15.4 M | 15.4 M | 15.4 M | 31.2 M | 31.2 M | 31.2 M | 31.2 M | 14.5 M | 14.5 M | 14.5 M | 14.5 M | 10.3 M | 10.3 M | 10.3 M | 10.3 M | 29.1 M | 29.1 M | 29.1 M | 29.1 M | 1.54 M | 1.54 M | 56.4 M | 56.4 M | 2.83 M | 54.5 M | 54.5 M | 54.5 M | 3.4 M | 82.2 M | 82.2 M | 82.2 M | 107 M | 107 M | 107 M | 107 M |
Book Value |
98.5 M | 93.3 M | 88.8 M | 78.5 M | 3.52 M | 5 M | 7.36 M | 11.6 M | 29.4 M | 79.1 M | 27.1 M | 41.1 M | 60.7 M | 85.2 M | 104 M | 76.1 M | 76.1 M | 76.1 M | 76.1 M | 68.3 M | 68.3 M | 68.3 M | 68.3 M | 120 M | 120 M | 120 M | 120 M | 30.8 M | 30.8 M | 30.8 M | 30.8 M | 16.1 M | 16.1 M | 16.1 M | 16.1 M | 31.4 M | 31.4 M | 31.4 M | 31.4 M | -475 K | -475 K | 109 M | 109 M | 1.63 M | 135 M | 135 M | 135 M | 176 M | 176 M | 176 M | 176 M | 174 M | 174 M | 174 M | 174 M |
Total Shareholders Equity |
63.2 M | 60.4 M | 56.6 M | -15.8 M | 85.3 M | 77.5 M | 77.3 M | -21.7 M | 29.4 M | 79.1 M | 27.1 M | 41.1 M | 60.7 M | 85.2 M | 104 M | 76.1 M | 76.1 M | 76.1 M | 76.1 M | 68.3 M | 68.3 M | 68.3 M | 68.3 M | 120 M | 120 M | 120 M | 120 M | 30.8 M | 30.8 M | 30.8 M | 30.8 M | 16.1 M | 16.1 M | 16.1 M | 16.1 M | 31.4 M | 31.4 M | 31.4 M | 31.4 M | -109 M | -109 M | 109 M | 109 M | -103 M | 135 M | 135 M | 135 M | -93.3 M | 176 M | 176 M | 176 M | 174 M | 174 M | 174 M | 174 M |
All numbers in USD currency